Established in 2013 as Pendlebury Research, our name was changed to Novatrials in 2019 to reflect our focus on new (Nova) treatments and being a part of the Novocastrian community. We conduct clinical trials across a range of conditions for people who find their condition is not well controlled by currently available treatments.